logo
Texas Instruments's (NASDAQ:TXN) Q2 Sales Top Estimates But Stock Drops

Texas Instruments's (NASDAQ:TXN) Q2 Sales Top Estimates But Stock Drops

Yahoo7 hours ago
Analog chip manufacturer Texas Instruments (NASDAQ:TXN) beat Wall Street's revenue expectations in Q2 CY2025, with sales up 16.4% year on year to $4.45 billion. The company expects next quarter's revenue to be around $4.63 billion, close to analysts' estimates. Its GAAP profit of $1.41 per share was 5.8% above analysts' consensus estimates.
Is now the time to buy Texas Instruments? Find out in our full research report.
Texas Instruments (TXN) Q2 CY2025 Highlights:
Revenue: $4.45 billion vs analyst estimates of $4.36 billion (16.4% year-on-year growth, 2% beat)
EPS (GAAP): $1.41 vs analyst estimates of $1.33 (5.8% beat)
Revenue Guidance for Q3 CY2025 is $4.63 billion at the midpoint, roughly in line with what analysts were expecting
EPS (GAAP) guidance for Q3 CY2025 is $1.48 at the midpoint, roughly in line with what analysts were expecting
Operating Margin: 35.1%, up from 32.7% in the same quarter last year
Free Cash Flow Margin: 12.5%, similar to the same quarter last year
Inventory Days Outstanding: 234, down from 243 in the previous quarter
Market Capitalization: $194.9 billion
Company Overview
Headquartered in Dallas, Texas since the 1950s, Texas Instruments (NASDAQ:TXN) is the world's largest producer of analog semiconductors.
Revenue Growth
Reviewing a company's long-term sales performance reveals insights into its quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Unfortunately, Texas Instruments's 4% annualized revenue growth over the last five years was sluggish. This fell short of our benchmark for the semiconductor sector and is a tough starting point for our analysis. Semiconductors are a cyclical industry, and long-term investors should be prepared for periods of high growth followed by periods of revenue contractions.
Long-term growth is the most important, but short-term results matter for semiconductors because the rapid pace of technological innovation (Moore's Law) could make yesterday's hit product obsolete today. Texas Instruments's performance shows it grew in the past but relinquished its gains over the last two years, as its revenue fell by 5.9% annually.
This quarter, Texas Instruments reported year-on-year revenue growth of 16.4%, and its $4.45 billion of revenue exceeded Wall Street's estimates by 2%. Company management is currently guiding for a 11.4% year-on-year increase in sales next quarter.
Looking further ahead, sell-side analysts expect revenue to grow 10.6% over the next 12 months, an improvement versus the last two years. This projection is particularly healthy for a company of its scale and implies its newer products and services will fuel better top-line performance.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Product Demand & Outstanding Inventory
Days Inventory Outstanding (DIO) is an important metric for chipmakers, as it reflects a business' capital intensity and the cyclical nature of semiconductor supply and demand. In a tight supply environment, inventories tend to be stable, allowing chipmakers to exert pricing power. Steadily increasing DIO can be a warning sign that demand is weak, and if inventories continue to rise, the company may have to downsize production.
This quarter, Texas Instruments's DIO came in at 234, which is 57 days above its five-year average. These numbers suggest that despite the recent decrease, the company's inventory levels are higher than what we've seen in the past.
Key Takeaways from Texas Instruments's Q2 Results
While Texas Instruments beat analysts' revenue and EPS expectations this quarter, revenue and EPS estimates for next quarter were just in line. It seems that the market was hoping for the strength this quarter to be reflected in the guide, and as a result, shares traded down 7.2% to $199.50 immediately following the results.
So should you invest in Texas Instruments right now? If you're making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it's free.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons
Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons

Yahoo

time7 minutes ago

  • Yahoo

Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons

BEACHWOOD, Ohio, July 23, 2025 /CNW/ -- Trailhead Biosystems, Inc. ( a biotechnology company pioneering the creation of induced pluripotent stem cell (iPSC)-derived human cells at scale for drug discovery and cell therapy, introduces TrailBio® A9 Dopaminergic Neurons, a powerful new tool available off-the-shelf for studying Parkinson's disease and other neurodegenerative conditions. A9 dopaminergic neurons play a critical role in movement regulation and are disproportionately affected in Parkinson's disease. Historically, researchers have lacked access to viable human models, relying instead on animal studies with limited relevance. With TrailBio® A9 Dopaminergic Neurons, scientists now have a human-specific platform to investigate disease mechanisms, develop therapies and accelerate drug discovery. "TrailBio® A9 Dopaminergic Neurons open new possibilities for Parkinson's research," said Dr. Jan Jensen, Chief Scientific Officer, Chief Technology Officer and founder of Trailhead Biosystems. "These cells enable researchers to study the vulnerabilities of A9 neurons, helping drive progress toward more effective treatments." "For decades, the lack of human A9 neurons has limited our ability to truly understand Parkinson's disease," added Dr. Nooshin Amini, Scientific Director at Trailhead Biosystems. "Now, with TrailBio® A9 Dopaminergic Neurons, researchers can directly study the exact cells that are most affected, offering hope for groundbreaking insights and future therapies." About Trailhead Biosystems Trailhead Biosystems, Inc. is pioneering an informatics-based approach in regenerative medicine and drug discovery. Founded in 2015 as a spinout from the Cleveland Clinic and Case Western Reserve University, Trailhead emerged from the research of CSO/CTO and founder Dr. Jan Jensen. Trailhead creates optimized human cells at scale with its proprietary High-Dimensional Design-of-Experiments (HD-DoE®) platform, integrating advanced mathematical modeling with high-throughput robotic manufacturing. This innovative system allows Trailhead to develop specialized, high-quality iPSC-derived human cells for drug discovery and cell-based therapies. TrailBio® A9 Dopaminergic Neurons represent one of many specialized human cell types emerging from this platform, with additional cell models expected in the near future. Learn more about Trailhead Biosystems, TrailBio® A9 Dopaminergic Neurons and HD-DoE® at For more information, please contact: Tim Mauk, Corporate CommunicationsTrailhead BiosystemsEmail: info@ View original content to download multimedia: SOURCE Trailhead Biosystems Inc View original content to download multimedia:

S&P 500 Is Getting More Bitcoin Exposure as Block Joins the Club
S&P 500 Is Getting More Bitcoin Exposure as Block Joins the Club

Yahoo

time7 minutes ago

  • Yahoo

S&P 500 Is Getting More Bitcoin Exposure as Block Joins the Club

Block, Jack Dorsey's Bitcoin-focused payments company, is set to join the S&P 500 on Wednesday, a milestone moment for both the company and and foray further into crypto for the benchmark index. Block (XYZ), which was rebranded from Square in 2021, is the second blockchain company to join the club after cryptocurrency exchange Coinbase Global (COIN) was added to the index in mid-May. That means index fund investors will get a modest bump in exposure to the world's largest cryptocurrency bitcoin (BTCUSD). The company takes the spot vacated by Hess Corp., which was acquired by Chevron (CVX) in a deal that closed July 18. It's the third addition of the month, following The Trade Desk (TTD) and Datadog (DDOG). Since the announcement of Block's inclusion late Friday, the shares have risen 9%. Block's stock has benefited from an index effect, which refers to directional pressure on stocks when a company is added to, or removed from, the S&P 500 and other indexes. The most recent research report on the matter from S&P Dow Jones Indices, which studied the price impact of index additions and deletions from 1995 to June 2021, showed that it isn't always much of a force. The median excess returns—defined here as the difference between a stock's total return and that of the broader index—of stocks added to the index, measured from the announcement date to the effective date, was about 8% from 1995 to 1999. From 2000 to 2010, that number shrank to 3.6%, and was essentially nonexistent from 2011 to 2021. And even if an index effect shows up ahead of the official inclusion or deletion date, according to a McKinsey study, the premium or discount has a tendency to dissipate within a few months. What's new can get old pretty fast. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

SAP Falls as Trade War Concerns Temper Strong Cloud Growth
SAP Falls as Trade War Concerns Temper Strong Cloud Growth

Yahoo

time7 minutes ago

  • Yahoo

SAP Falls as Trade War Concerns Temper Strong Cloud Growth

(Bloomberg) -- SAP SE shares fell after the German software company flagged concerns about tariff insecurities and currency fluctuations even as cloud revenue posted solid growth. Trump Awards $1.26 Billion Contract to Build Biggest Immigrant Detention Center in US Why the Federal Reserve's Building Renovation Costs $2.5 Billion Salt Lake City Turns Winter Olympic Bid Into Statewide Bond Boom Milan Corruption Probe Casts Shadow Over Property Boom How San Jose's Mayor Is Working to Build an AI Capital Cloud and software revenue increased 11% to €7.97 billion ($9.4 billion) in the period ended June 30, the Walldorf, Germany-based company said Tuesday in a statement. That compares to analysts' average estimate of €7.99 billion, according to data compiled by Bloomberg. The company has shown resilient cloud growth in the face of geopolitical instability, as customers who decide to switch from on-premise servers typically commit to complex, multiyear migration projects that can't easily be dialed back. SAP's stock soared over the past year, and the company surpassed Dutch chip machine maker ASML Holding NV to become Europe's most valuable business. Persistent uncertainties are increasing pressure on global trade and customers find it harder 'to make well-informed decisions,' Chief Financial Officer Dominik Asam said on an investor call after the results. He added management is preparing SAP 'for less favorable outcomes' to protect the bottom line and free cash flow this year. SAP shares fell 2.4% to €253.20 at 10:11 a.m. in Frankfurt on Wednesday. While the company maintained its annual forecast for cloud revenue, it expects currency fluctuations to hurt that growth by 3.5 percentage points. SAP is facing 'deal cycle elongation in its complex manufacturing customer base' and the US public sector that could impact its business, KeyBanc Capital Markets analysts Jackson Ader and Jack Nichols said in a note. The results were in line with their expectations, they added. SAP sells software to companies to run business functions such as finances, human resources and procurement. Over the past two years, it has promoted artificial intelligence services to encourage clients to shift from legacy on-site servers to IT infrastructure in the cloud, where average spending per client is higher. SAP's largest market is the US, which represents more than 30% of its sales. The weakened dollar poses currency pressures for the company. Cloud revenue increased 24% to €5.13 billion, excluding currency fluctuations, which was slightly below analysts' expectations. SAP's cloud backlog, an indicator of future cloud sales, increased to €18.1 billion in the second quarter, missing analysts' expectations of €18.5 billion. The number measures how much cloud revenue SAP signed to come in over the next 12 months. The company also said it 'continues to expect current cloud backlog growth at constant currencies to slightly decelerate in 2025.' About half of SAP's revenue and more than half of its operational profit were denominated in US dollars or correlated currencies, Asam said in a media call after the results. A devaluation of the dollar of 1% meant SAP was roughly losing half a percentage point of growth, according to Asam. 'We are facing a significant currency headwind this year,' he said. Investors are watching the effect of currency fluctuations on next year's outlook, according to Rob Hales, a senior equity analyst at Morningstar. 'It could move the stock when we start getting indications from management on the potential impact of currency next year,' he said. SAP has probably significantly increased the incentives it offers customers for their cloud migration, which could impact cash flow next year, UBS Group AG analysts including Michael Briest said in a note last week. (Updates with CFO and analyst comments starting in fourth paragraph.) Elon Musk's Empire Is Creaking Under the Strain of Elon Musk Burning Man Is Burning Through Cash A Rebel Army Is Building a Rare-Earth Empire on China's Border Thailand's Changing Cannabis Rules Leave Farmers in a Tough Spot How Starbucks' CEO Plans to Tame the Rush-Hour Free-for-All ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store